These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 31514066)
1. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer. Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066 [TBL] [Abstract][Full Text] [Related]
2. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma. Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591 [TBL] [Abstract][Full Text] [Related]
3. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma. Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery. Li H; Pan X; Gui Y; Quan J; Li Z; Zhao L; Guan X; Xu J; Xu W; Lai Y Cancer Biomark; 2019; 24(2):153-158. PubMed ID: 30689558 [TBL] [Abstract][Full Text] [Related]
5. Liu Q; Lei C Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622 [TBL] [Abstract][Full Text] [Related]
6. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer. Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis. Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244 [TBL] [Abstract][Full Text] [Related]
8. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis. Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566 [TBL] [Abstract][Full Text] [Related]
9. Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients. Liu K; Pan X; Peng X; Zhang C; Li H; Guan X; Xu W; Xu J; Zhao L; Wang T; Lai Y Pathol Res Pract; 2019 Jun; 215(6):152391. PubMed ID: 31076282 [TBL] [Abstract][Full Text] [Related]
10. miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancer. Zhang C; Pan X; Peng X; Liu K; Wang J; Zhao L; Chen X; Huang G; Li H; Ye J; Lai Y J Clin Lab Anal; 2021 Feb; 35(2):e23599. PubMed ID: 33247622 [TBL] [Abstract][Full Text] [Related]
11. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1). Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305 [TBL] [Abstract][Full Text] [Related]
12. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma. Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression. Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630 [TBL] [Abstract][Full Text] [Related]
14. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC. Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118 [TBL] [Abstract][Full Text] [Related]
15. MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma. Wang XG; Zhu YW; Wang T; Chen B; Xing JC; Xiao W Kaohsiung J Med Sci; 2021 Mar; 37(3):192-199. PubMed ID: 33151036 [TBL] [Abstract][Full Text] [Related]
16. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma. Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711 [TBL] [Abstract][Full Text] [Related]
17. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15. Deng JH; Zheng GY; Li HZ; Ji ZG Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538 [TBL] [Abstract][Full Text] [Related]
18. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis. Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma. Zhou L; Pan X; Li Z; Chen P; Quan J; Lin C; Lai Y; Xu J; Xu W; Guan X; Li H; Gui Y; Lai Y Biomed Pharmacother; 2018 Sep; 105():1155-1163. PubMed ID: 30021352 [TBL] [Abstract][Full Text] [Related]
20. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression. Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]